Neural Stem Cell Priming for Region-Specific Differentiation

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current methods fail to effectively direct pluripotent or multipotent stem cells to differentiate into specific neuronal types, such as cholinergic, glutamatergic, or GABAergic neurons, when transplanted into non-neurogenic areas of the adult CNS, limiting their therapeutic potential for neurological disorders.

Innovation Solution

Adhesively culturing neural stem cells with a mixture of mitogenic growth factors, heparin-like agents, and extracellular matrix components, followed by implantation into specific regions of the brain or spinal cord, where they differentiate into desired neuronal phenotypes, with at least 50% of the neurons formed being cholinergic, glutamatergic, or GABAergic.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If stem cells are transplanted into non-neurogenic areas of the adult CNS, then the cells can be implanted in various brain regions, but the cells remain undifferentiated or become mainly glial cells instead of specific neuronal types

Engineering Contradiction:

Improvetransplantation location flexibilityVSAvoidneuronal differentiation specificity

Core Design Contradiction:

Adaptability or versatilityVSManufacturing precision

Solution Approach 1:

The patent applies preliminary action by culturing stem cells in vitro with specific growth factors (bFGF, NT-3, BDNF) and extracellular matrix components (laminin, poly-D-lysine) before transplantation to prime them for neuronal differentiation. This pre-treatment ensures that when cells are implanted in non-neurogenic areas, they are already committed to becoming specific neuronal types rather than remaining undifferentiated or becoming glial cells.

Inventive Principle:

Principle #10Preliminary action

Solution Approach 2:

The patent changes physical and chemical parameters of the culture environment including growth factor concentrations (bFGF at 10-100 ng/ml, NT-3 at 10-100 ng/ml, BDNF at 10-100 ng/ml), extracellular matrix composition (laminin at 10-100 μg/ml, poly-D-lysine at 10-100 μg/ml), and culture conditions to direct stem cell differentiation toward specific neuronal phenotypes before transplantation.

Inventive Principle:

Principle #35Parameter changes

2Ease of manufacture

If stem cells are cultured without specific differentiation factors, then the culture process is simpler, but the cells do not differentiate into desired neuronal subtypes after implantation

Engineering Contradiction:

Improveculture process simplicityVSAvoidneuronal subtype differentiation

Core Design Contradiction:

Ease of manufactureVSManufacturing precision

Solution Approach 1:

The patent modifies culture parameters by adding specific growth factors (bFGF, NT-3, BDNF) and extracellular matrix components (laminin, poly-D-lysine) at defined concentrations to the culture medium. This controlled parameter change directs stem cell differentiation toward specific neuronal types while maintaining a relatively straightforward culture protocol that can be implemented in standard laboratory settings.

Inventive Principle:

Principle #35Parameter changes

Data Source

PatentUS8058063B2Method of producing region-specific neurons from human neuronal stem cells

Publication Date: 2011.11.15 BOARD OF RGT THE UNIV OF TEXAS SYST

AI summary

A method of priming neural stem cells in vitro by adhesively culturing in a mixture of basic fibroblast growth factor, laminin and heparin to differentiate into specific neuronal phenotypes, including cholinergic, glutamatergic and GABAergic neurons, in a region-specific manner, when transplanted in vivo.